Opko Health, Inc. (OPK) Financials
OPK Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 2.0 billion | 622.5 million |
2023-09-30 | 2.1 billion | 612.1 million |
2023-06-30 | 2.2 billion | 623.6 million |
2023-03-31 | 2.2 billion | 617.8 million |
OPK Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -41.3 million | 2.7 million |
2023-09-30 | 28.9 million | 3.2 million |
2023-06-30 | -6.4 million | 2.8 million |
2023-03-31 | -25.7 million | 2.7 million |
OPK Net Income
No data available :(
OPK Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 95.9 million | - | 77.2 million |
2023-09-30 | 138.6 million | - | 56.5 million |
2023-06-30 | 108.1 million | - | 46.2 million |
2023-03-31 | 110.8 million | - | 48.8 million |
OPK Shares Outstanding
OPK Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 3.0 million | 19.4 million | 72.9 million | - |
2023-09-30 | 4.2 million | 19.4 million | 72.3 million | - |
2023-06-30 | 6.0 million | 18.2 million | 79.8 million | - |
2023-03-31 | 3.0 million | 32.6 million | 75.8 million | - |
OPK Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 181.9 million | 158.7 million |
2023-09-30 | 178.6 million | 130.9 million |
2023-06-30 | 265.4 million | 138.9 million |
2023-03-31 | 237.6 million | 138.3 million |
OPK
Price: $1.27
52 week price:
Earnings Per Share: -0.25 USD
P/E Ratio: -3.71
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 3.2 million
Ebitda: -39.6 millionMarket Capitalization: 857.3 million